Biomea Fusion Inc (BMEA) - News Archive

Biomea Fusion s BMF-219: A Promising Breakthrough in the Pursuit to Cure Type 1 DiabetesIn a revolutionary stride towards finding a cure for Type 1 diabetes, Biomea Fusion has received Health Canada s significant cleara...

Biomea Fusion, a renowned biopharmaceutical company, has recently unveiled its groundbreaking research on the efficacy of their novel menin inhibitor, BMF-219, in achieving durable glycemic control in diabetes patients....

Biomea Fusion Presents New Data from the Ongoing COVALENT-111 Study of BMF-219 in Patients with Type 2 Diabetes at the World Congress Insulin Resistance, Diabetes & Cardiovascular DiseaseIn a bold move towards revolutio...